Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma.

被引：0
|
作者：
Warner, Allison Betof [1 ]
Shoushtari, Alexander Noor [1 ]
Houghton, Sean [1 ]
Panageas, Katherine [1 ]
Chapman, Paul B. [1 ]
Wolchok, Jedd D. [1 ]
Postow, Michael A. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9552
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma.
    Lee, Chung-Han
    Di Natale, Renzo G.
    Chowell, Diego
    Makarov, Vladimir
    Redzematovic, Almedina
    Murray, Samuel J.
    Carlo, Maria Isabel
    Voss, Martin Henner
    Feldman, Darren R.
    Motzer, Robert J.
    Chan, Timothy An-Thy
    Hakimi, A. Ari
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [32] Nivolumab (NIVO) plus ipilimumab (IPI) plus cabozantinib (CABO) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040
    Yau, Thomas
    Zagonel, Vittorina
    Santoro, Armando
    Acosta-Rivera, Mirelis
    Choo, Su Pin
    Matilla, Ana
    He, Aiwu Ruth
    Gracian, Antonio Cubillo
    El-Khoueiry, Anthony B.
    Sangro, Bruno
    Eldawy, Tarek
    Bruix, Jordi
    Frassineti, Giovanni
    Vaccaro, Gina M.
    Tschaika, Marina
    Scheffold, Christian
    Shen, Yun
    Neely, Jaclyn
    Piscaglia, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [33] Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (MBM; CheckMate 204)
    Tawbi, Hussein
    Forsyth, Peter
    Hodi, F. Stephen
    Lao, Christopher
    Moschos, Stergios
    Hamid, Omid
    Atkins, Michael B.
    Lewis, Karl
    Thomas, Reena P.
    Glaspy, John A.
    Jang, Sekwon
    Algazi, Alain
    Khushalani, Nikhil I.
    Postow, Michael A.
    Pavlick, Anna C.
    Ernstoff, Marc
    Reardon, David A.
    Balogh, Agnes
    Rizzo, Jasmine
    Margolin, Kim
    BRITISH JOURNAL OF CANCER, 2019, 121 : 20 - 20
  • [34] Phase 2 study to evaluate efficacy and safety of combination therapy with nivolumab (NIVO) and ipilimumab(IPI) in patients with previously untreated melanoma
    Kiyohara, Y.
    Takenouchi, T.
    Uhara, H.
    Koga, H.
    Uchi, H.
    Yamazaki, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [35] Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204
    Huang, R.
    Youssef, G.
    Nelson, T.
    Wen, P.
    Forsyth, P.
    Hodi, F. S.
    Margolin, K. A.
    Algazi, A. P.
    Hamid, O.
    Lao, C. D.
    Ernstoff, M. S.
    Moschos, S. J.
    Atkins, M. B.
    Postow, M.
    Reardon, D. A.
    Grootendorst, D. J.
    Askelson, M.
    Ritchings, C.
    Tawbi, H. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S680 - S681
  • [36] Age-dependent Efficacy and Safety of Nivolumab (NIVO) as Monotherapy or Combination Therapy with Ipilimumab (NIVO plus IPI) in Patients with advanced Melanoma in the non-interventional Study (NIS) NICO
    Schadendorf, D.
    Ugurel, S.
    Eigentler, T.
    Mohr, P.
    Wei-Chenthal, M.
    Gebhardt, C.
    Goppner, D.
    Haferkamp, S.
    Herbst, R.
    Kahler, K.
    Kreuter, A.
    Meier, F.
    Pfohler, C.
    Sachse, M. M.
    Sickmann, T.
    Terheyden, P.
    Ulrich, J.
    Utikal, J. S.
    Grimmel-Mann, I.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 16 - 17
  • [37] Adjuvant therapy with nivolumab (NIVO) combined with ipilimumab (IPI) vs NIVO alone in patients (pts) with resected stage IIIB-D/IV melanoma (CheckMate 915).
    Long, Georgina V.
    Schadendorf, Dirk
    Del Vecchio, Michele
    Larkin, James
    Atkinson, Victoria
    Schenker, Michael
    Pigozzo, Jacopo
    Gogas, Helen J.
    Dalle, Stephane
    Meyer, Nicolas
    Ascierto, Paolo A.
    Sandhu, Shahneen
    Eigentler, Thomas
    Gutzmer, Ralf
    Hassel, Jessica C.
    Robert, Caroline
    Carlino, Matteo
    Di Giacomo, Anna Maria
    Butler, Marcus O.
    Munoz-Couselo, Eva
    Brown, Michael P.
    Rutkowski, Piotr
    Haydon, Andrew
    Grob, Jean-Jacques
    Schachter, Jacob
    Queirolo, Paola
    Menzies, Alexander
    Re, Sandra
    Bas, Tuba O.
    de Pril, Veerle
    Tenney, Daniel
    Tang, Hao
    Weber, Jeffrey S.
    CANCER RESEARCH, 2021, 81 (13)
  • [38] Updated results from a phase III trial of nivolumab (NIVO) combined with ipilimumab (IPI) in treatment-naive patients (pts) with advanced melanoma (MEL) (CheckMate 067).
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Rutkowski, Piotr
    Grob, Jean Jacques
    Cowey, C. Lance
    Lao, Christopher
    Schadendorf, Dirk
    Ferrucci, Pier Francesco
    Smylie, Michael
    Dummer, Reinhard
    Hill, Andrew
    Haanen, John B. A. G.
    Maio, Michele
    McArthur, Grant A.
    Walker, Dana
    Jiang, Joel
    Horak, Christine E.
    Larkin, James M. G.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM).
    Pelster, Meredith
    Gruschkus, Stephen K.
    Bassett, Roland
    Gombos, Dan S.
    Shephard, Michael
    Posada, Liberty
    Glover, Maura
    Diab, Adi
    Hwu, Patrick
    Patel, Sapna Pradyuman
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Initial report of overall survival rates from a randomized phase II trial evaluating the combination of nivolumab (NIVO) and ipilimumab (IPI) in patients with advanced melanoma (MEL)
    Postow, Michael
    Chesney, Jason
    Pavlick, Anna
    Robert, Caroline
    Grossmann, Kenneth
    McDermott, David
    Linette, Gerald
    Meyer, Nicolas
    Giguere, Jeffrey
    Agarwala, Sanjiv
    Shaheen, Montaser
    Ernstoff, Marc
    Minor, David
    Salama, April
    Taylor, Matthew
    Ott, Patrick
    Jiang, Joel
    Horak, Christine
    Gagnier, Paul
    Wolchok, Jedd
    Hodi, F. Stephen
    CANCER RESEARCH, 2016, 76
12345